• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便培养及毒素检测在儿童艰难梭菌所致抗生素相关性腹泻中的诊断作用

Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children.

作者信息

Gogate A, De A, Nanivadekar R, Mathur M, Saraswathi K, Jog A, Kulkarni M V

机构信息

Department of Microbiology , L.T.M. Medical College, Mumbai, India.

出版信息

Indian J Med Res. 2005 Dec;122(6):518-24.

PMID:16518003
Abstract

BACKGROUND & OBJECTIVE: Mere diagnosis of Clostridium difficile by culture does not help in the diagnosis of antibiotic associated diarrhoeae (AAD) due to C. difficile. Detection of toxins A and B form the mainstay in the diagnosis of AAD due to C. difficile. This study was undertaken to find out the role of stool culture and toxin detection in the diagnosis of AAD due to C. difficile. As there are very few documented reports from India about AAD due to C. difficile in children in the age group of 5-12 yr, this age group was selected.

METHODS

Faecal samples were collected from 250 hospitalized children in the age group of 5-12 yr who developed diarrhoea on receiving antibiotics for different medical problems for more than five days duration. Also faecal samples of 250 age and sex matched controls were collected. Culture for C. difficile was done on cycloserine cefoxitin fructose egg yolk agar (CCFA) and colonies were identified by standard laboratory techniques. ELISA for toxins A and B detection and tissue culture on HeLa cells for toxin B detection were also done.

RESULTS

Overall positivity was 18 per cent in this study group compared to the controls (P<0.001). Maximum positive cases were in 5-8 yr age group (84.4%). Severe diarrhoea, liquid stool with mucus and blood, faecal leucocytes >5/high power field, altered flora and presence of Gram-positive bacilli with oval subterminal spores on Gram stain were sensitive predictors for diagnosis of AAD due to C. difficile. Amongst positive cases, 68.9 per cent responded to discontinuation of antibiotics and 31.1 per cent to metronidazole therapy.

INTERPRETATION & CONCLUSION: C. difficile was an important pathogen responsible for antibiotic associated diarrhoea (AAD) in children of 5-12 yr age group. Conservative use of antibiotics would be beneficial to decrease the incidence of AAD.

摘要

背景与目的

仅通过培养诊断艰难梭菌无助于诊断由艰难梭菌引起的抗生素相关性腹泻(AAD)。毒素A和B的检测是诊断由艰难梭菌引起的AAD的主要依据。本研究旨在探讨粪便培养和毒素检测在诊断由艰难梭菌引起的AAD中的作用。由于印度关于5至12岁儿童由艰难梭菌引起的AAD的文献报道极少,因此选择了该年龄组。

方法

收集了250名年龄在5至12岁、因不同医疗问题接受抗生素治疗超过5天且出现腹泻的住院儿童的粪便样本。同时收集了250名年龄和性别匹配的对照儿童的粪便样本。在环丝氨酸头孢西丁果糖蛋黄琼脂(CCFA)上进行艰难梭菌培养,并通过标准实验室技术鉴定菌落。还进行了毒素A和B的ELISA检测以及在HeLa细胞上进行毒素B检测的组织培养。

结果

与对照组相比,本研究组的总体阳性率为18%(P<0.001)。阳性病例最多的是5至8岁年龄组(84.4%)。严重腹泻、伴有黏液和血液的水样便、粪便白细胞>5/高倍视野、菌群改变以及革兰氏染色显示有带椭圆形亚末端孢子的革兰氏阳性杆菌是诊断由艰难梭菌引起的AAD的敏感预测指标。在阳性病例中,68.9%对抗生素停用有反应,31.1%对甲硝唑治疗有反应。

解读与结论

艰难梭菌是5至12岁儿童抗生素相关性腹泻(AAD)的重要病原体。谨慎使用抗生素将有助于降低AAD的发生率。

相似文献

1
Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children.粪便培养及毒素检测在儿童艰难梭菌所致抗生素相关性腹泻中的诊断作用
Indian J Med Res. 2005 Dec;122(6):518-24.
2
[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].[对从马尔马拉大学医院腹泻住院患者中分离出的艰难梭菌菌株毒素基因的研究]
Mikrobiyol Bul. 2011 Jan;45(1):1-10.
3
[Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].[采用培养和毒素检测方法调查抗生素相关性腹泻患者中艰难梭菌的存在情况]
Mikrobiyol Bul. 2007 Jan;41(1):29-37.
4
Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.一家三级护理医院中艰难梭菌相关性腹泻的发病率。
J Assoc Physicians India. 2012 Nov;60:26-8.
5
Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.抗生素相关性腹泻患者粪便样本中艰难梭菌毒素A和B以及产气荚膜梭菌肠毒素A的患病率。
Infection. 2005 Oct;33(5-6):340-4. doi: 10.1007/s15010-005-5067-3.
6
[The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].[中性粒细胞减少和非中性粒细胞减少的抗生素相关性腹泻患者中艰难梭菌毒素的频率及危险因素分析]
Mikrobiyol Bul. 2008 Oct;42(4):573-83.
7
[Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].[因急性腹泻住院儿童粪便标本中的艰难梭菌毒素A及其他肠道病原体]
Przegl Epidemiol. 2005;59(3):711-21.
8
[Intestinal flora of patients with suspected antibiotic associated diarrhea (AAD). I. Clostridium perfringens].[疑似抗生素相关性腹泻(AAD)患者的肠道菌群。I. 产气荚膜梭菌]
Med Dosw Mikrobiol. 2000;52(4):375-82.
9
Clostridium perfringens type A & antibiotic associated diarrhoea.A型产气荚膜梭菌与抗生素相关性腹泻
Indian J Med Res. 2005 Jul;122(1):52-6.
10
["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].艰难梭菌细胞毒素B在抗生素治疗相关腹泻病程中的“二次观察”
Pathol Biol (Paris). 1999 May;47(5):415-21.

引用本文的文献

1
Systematic Literature Review on Burden of difficile Infection in India.印度艰难梭菌感染负担的系统文献综述
Clin Pathol. 2021 May 31;14:2632010X211013816. doi: 10.1177/2632010X211013816. eCollection 2021 Jan-Dec.
2
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2019 Apr 30;4(4):CD004827. doi: 10.1002/14651858.CD004827.pub5.
3
Toxigenic isolates from clinically significant diarrhoea in patients from a tertiary care centre.从一家三级护理中心的临床显著腹泻患者中分离出产毒株。
Indian J Med Res. 2017 Jun;145(6):840-846. doi: 10.4103/ijmr.IJMR_192_16.
4
Use of culture- and ELISA-based toxin assay for detecting , a neglected pathogen: A single-center study from a tertiary care setting.使用基于培养和酶联免疫吸附测定的毒素检测方法检测一种被忽视的病原体:来自三级医疗机构的单中心研究。
J Lab Physicians. 2017 Oct-Dec;9(4):254-259. doi: 10.4103/JLP.JLP_157_16.
5
The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review.艰难梭菌在儿童和新生儿肠道中的作用——一篇叙述性综述。
Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1047-57. doi: 10.1007/s10096-016-2639-3. Epub 2016 Apr 23.
6
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.儿童与成人抗生素相关性腹泻及艰难梭菌感染的比较
World J Gastroenterol. 2016 Mar 21;22(11):3078-104. doi: 10.3748/wjg.v22.i11.3078.
7
Fidaxomicin--the new drug for Clostridium difficile infection.非达霉素——治疗艰难梭菌感染的新药。
Indian J Med Res. 2015 Apr;141(4):398-407. doi: 10.4103/0971-5916.159251.
8
Prevalence of clostridium difficile among paediatric patients in a tertiary care hospital, coastal karnataka, South India.印度南部卡纳塔克邦沿海地区一家三级护理医院儿科患者艰难梭菌的患病率
J Clin Diagn Res. 2015 Feb;9(2):DC04-7. doi: 10.7860/JCDR/2015/11000.5534. Epub 2015 Feb 1.
9
The impact of Clostridium difficile on paediatric surgical practice: a systematic review.艰难梭菌对小儿外科实践的影响:一项系统综述
Pediatr Surg Int. 2014 Aug;30(8):853-9. doi: 10.1007/s00383-014-3543-5. Epub 2014 Jul 10.
10
Epidemiology of Clostridium difficile infection in Asia.亚洲艰难梭菌感染的流行病学。
Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21.